Comparison of Two Robotic-Assisted Total Knee Arthroplasty Systems

NCT ID: NCT06284824

Last Updated: 2024-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-31

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this prospective study is to compare two different knee replacement robots. This study will look at patient reported outcome measures and data collected during the operation. The main questions this study aims to answer include:

* Will the patient reported outcomes differ between the two groups?
* Will the intraoperative data differ between the two groups? Participants will undergo total knee replacement with one of the two robots, complete standardized surveys, and have x-rays taken.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to compare two different total knee arthroplasty (TKA) robotic assisted (RA) devices. This study will compare patient reported outcome measures prior to and after surgery. These surveys will be used determine if there are differences in patient recovery after TKA depending on the robot used. Radiographs will also be taken and used to compare component positioning. Intraoperative data will be collected to compare OR efficiency of the two systems.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Knee Arthritis Knee Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAKO group

Patients in this arm will receive the Stryker Triathlon implant and the MAKO robotic arm will be used during surgery.

Group Type EXPERIMENTAL

Stryker Triathlon with MAKO Robotic-Arm

Intervention Type DEVICE

Implant is the Stryker Triathlon total knee arthroplasty and the robotic device is the MAKO robotic-arm

VELYS group

Patients in this arm will receive the DePuy Attune implant and the VELYS robotic arm will be used during surgery.

Group Type EXPERIMENTAL

DePuy Attune with VELYS Robotic-Assistance

Intervention Type DEVICE

Implant is the DePuy Attune total knee arthroplasty and the robotic device is the VELYS robotic-assistance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stryker Triathlon with MAKO Robotic-Arm

Implant is the Stryker Triathlon total knee arthroplasty and the robotic device is the MAKO robotic-arm

Intervention Type DEVICE

DePuy Attune with VELYS Robotic-Assistance

Implant is the DePuy Attune total knee arthroplasty and the robotic device is the VELYS robotic-assistance

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient must be a candidate for primary TKA (either Stryker Triathlon with MAKO Robotic-Arm or DePuy Attune with VELYS Robotic-Assistance).
* Individuals who are able to speak, read, and comprehend the Institutional Review Board approved Informed Consent Document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of information to the Sponsor.
* Individuals who are willing and able to complete follow up visits, questionnaires, and radiographic evaluations as specified by the study protocol.
* Individuals who are male or non-pregnant female age 18-80 years at time of device implantation.
* Patient has a diagnosis of primary osteoarthritis or degenerative joint disease of the knee.

Exclusion Criteria

* Patient has a Body Mass Index (BMI) \> 40.
* Patient has been diagnosed with osteoporosis or displays poor bone quality per the discretion of the investigator.
* Patient has an active or suspected latent infection in affected knee joint. Patient has neuromuscular or neurosensory deficiency.
* Patient is diagnosed with systemic disease or metabolic disorder (e.g., Lupus, Charcot's. Paget's).
* Subject is a woman who is pregnant or lactating.
* Patient has a contralateral amputation.
* Patient's affected knee has a flexion contracture greater than 15 degrees.
* Patient has history of post operative arthrofibrosis.
* Patient's affected knee has a partial knee arthroplasty.
* Patient has undergone contralateral TKA within the last three months.
* Patient is currently involved in any personal injury litigation, medical-legal, or worker's compensation claims.
* Patient who is bedridden per the discretion of the investigator.
* Patient has a medical condition with less than 2 years of life expectancy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

DePuy Orthopaedics

INDUSTRY

Sponsor Role collaborator

Stryker Orthopaedics

INDUSTRY

Sponsor Role collaborator

Southeast Orthopedic Specialists

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Redmond, MD

Role: PRINCIPAL_INVESTIGATOR

Southeast Orthopedic Specialists

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexis Velez, BS

Role: CONTACT

13214439922

John Redmond, MD

Role: CONTACT

9043286711

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DPS-JMP-2022-040

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Outcomes of Joint Arthroplasty
NCT03668691 ACTIVE_NOT_RECRUITING
Medacta NextAR TKA Pivotal Trial
NCT04844879 COMPLETED NA